A Blood Test That Screens 50+ Cancers Moves Closer
A breakthrough blood test that screens for 50+ cancers is edging toward real-world use. This article breaks down what...
Post-mistake savings require quick wins and steady progress: cut nonessential costs, automate savings, and reassess your priorities.
21,607 articlesA breakthrough blood test that screens for 50+ cancers is edging toward real-world use. This article breaks down what...
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
In 2026, investors face a clash between disruption and durability: Archer Aviation as a high-growth upstart and Boein...
U.S. airline stocks rise on easing fuel costs, led by American Airlines and United, as crude prices slip and margins ...
A meme-focused token from MemeCore dropped roughly 70%, sending its market cap below $1 billion and triggering renewe...
Cynthia Lummis gave clarity on timing for the CLARITY Act, but the Senate path remains uncertain as lawmakers juggle ...
FuelCell Energy surges on a major data-center deal, while Bloom Energy retreats, underscoring a rare divergence in th...
The 2026 multifamily crash reshapes how lenders and sponsors think about risk and return. This guide explains what we...
Target is adopting a points-based attendance policy for frontline workers, starting September, with strict penalties ...
The Nasdaq Composite capped a powerful Q2 but cooled in late trading as oil prices steadied. Futures hint at a quiet ...
SpaceX is counting down to a defining moment within two weeks. This guide explains what the milestone could mean for ...
A looming 10-year treasury signal could temper SCHD's 2026 rally as rising yields threaten valuations for dividend-fo...